InsidersTradesSigma
Track the NewAmsterdam Pharma Company N.V. share price and the full management transaction log of the company, a publicly traded company based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). The latest transaction was disclosed on 25 August 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: Kastelein Johannes Jacob Pieter. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
NewAmsterdam Pharma Company N.V. is a biopharmaceutical company focused on developing innovative treatments for cardiometabolic diseases. It is listed on NASDAQ under the ticker symbol NAMS.